Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease

Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease

Alanine–serine–cysteine transporter 2 (ASCT2) is reported to participate in the progression of tumors and metabolic diseases. It is also considered to play a crucial role in the glutamate-glutamine shuttle of neuroglial network. However, it remains unclear the involvement of ASCT2 in neurological di...

Full description

Bibliographic Details
Main Authors:	Yang Liu, Ting Liu, Yuanzhang Zhou, Wenjie Li, Min Wang, Nanshan Song, Wenbin Zhang, Jingwei Jiang, Shengtao Yuan, Jianhua Ding, Gang Hu, Ming Lu
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	ASCT2 NLRP3 Astrocytes Inflammation Neurodegeneration Drug screening
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383522003343

Similar Items

Research Progress of Glutamine Transporter ASCT2 in Cancer
by: WANG Yale, et al.
Published: (2019-03-01)

The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial
by: Alina Striha, et al.
Published: (2018-03-01)

Methamphetamine-mediated astrocytic pyroptosis and neuroinflammation involves miR-152–NLRP6 inflammasome signaling axis
by: Abiola Oladapo, et al.
Published: (2025-03-01)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
by: Yijun Luo, et al.
Published: (2020-05-01)

GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma
by: Afaf T. Ibrahiem, et al.
Published: (2024-07-01)

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
by: Luca eSteardo, et al.
Published: (2015-07-01)

Successful bridging therapy with tirabrutinib before ASCT for relapsed primary DLBCL of the CNS complicated with PBC, cirrhosis, and pancytopenia
by: Noriharu Nakagawa, et al.
Published: (2022-01-01)

Effect of NLRP3 inflammasome induced astrocyte phenotype alteration in morphine tolerance
by: Zhenyu Yuan, et al.
Published: (2024-11-01)

Diminazene Ameliorates Neuroinflammation by Suppression of Astrocytic miRNA-224-5p/NLRP3 Axis in Alzheimer’s Disease Model
by: Sun X, et al.
Published: (2023-04-01)

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells
by: Wei Yu, et al.
Published: (2022-03-01)

The role and mechanism of NLRP3 inflammasome-mediated astrocyte activation in dehydrocorydaline against CUMS-induced depression
by: Yu Fang, et al.
Published: (2022-11-01)

Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt’s lymphoma with TP53 mutations
by: Qi Zhang, et al.
Published: (2023-03-01)

Astrocytic NLRP3 cKO mitigates depression-like behaviors induced by mild TBI in mice.
by: Hui-Tao Miao, et al.
Published: (2025-02-01)

Editorial: The NLRP3 inflammasome-mediated neuroinflammation and its related mitochondrial impairment in neurodegeneration
by: Chao Deng, et al.
Published: (2023-01-01)

Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
by: Yuta Hara, et al.
Published: (2020-01-01)

The ABC transporter A7 modulates neuroinflammation via NLRP3 inflammasome in Alzheimer’s disease mice
by: Irene Santos-García, et al.
Published: (2025-01-01)

CuII(atsm) Attenuates Neuroinflammation
by: Xin Yi Choo, et al.
Published: (2018-09-01)

Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression
by: Ren-Hong Du, et al.
Published: (2016-10-01)

Astrocyte-derived exosomal miR-378a-5p mitigates cerebral ischemic neuroinflammation by modulating NLRP3-mediated pyroptosis
by: Ruiting Sun, et al.
Published: (2024-08-01)

Astrocytes and Aging
by: Alexandra L. Palmer, et al.
Published: (2018-10-01)

Editorial: Neuroinflammation and neurodegeneration from bench to bedside
by: Wael M. Y. Mohamed, et al.
Published: (2023-10-01)

A new perspective on the regulation of neuroinflammation in intracerebral hemorrhage: mechanisms of NLRP3 inflammasome activation and therapeutic strategies
by: Kai-long He, et al.
Published: (2025-02-01)

NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia
by: Ningning She, et al.
Published: (2022-11-01)

Roles of neuropathology-associated reactive astrocytes: a systematic review
by: Jill M. Lawrence, et al.
Published: (2023-03-01)

Delayed transplantation of precursor cell‐derived astrocytes provides multiple benefits in a rat model of Parkinsons
by: Christoph Proschel, et al.
Published: (2014-01-01)

Discovery and Synthesis of Hydroxy-<span style="font-variant: small-caps">l</span>-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2)
by: Brent R. Lyda, et al.
Published: (2024-05-01)

Inhibition of ASCT2 is essential in all‐trans retinoic acid‐induced reduction of adipogenesis in 3T3‐L1 cells
by: Katsuhiko Takahashi, et al.
Published: (2015-01-01)

NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist
by: Meng He, et al.
Published: (2022-05-01)

The Regulation and Function of the Amino Acid Transporters LAT1, ASCT2, xCT in Urological Cancers
by: Xue Zhao, et al.
Published: (2024-10-01)

Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury
by: Juanji Li, et al.
Published: (2023-06-01)

LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
by: Francisca Dias, et al.
Published: (2021-02-01)

The role of HIV-1 DNA levels in HIV-related lymphoma patients treated with autologous stem cell transplantation (ASCT)
by: Maria Teresa Bortolin, et al.
Published: (2010-09-01)

The AST-120 Recovers Uremic Toxin-Induced Cognitive Deficit via NLRP3 Inflammasome Pathway in Astrocytes and Microglia
by: Lung-Chih Li, et al.
Published: (2021-09-01)

Astrocyte Heterogeneity in the Adult Central Nervous System
by: Sean J. Miller
Published: (2018-11-01)

Astrocytes of the eye and optic nerve: heterogeneous populations with unique functions mediate axonal resilience and vulnerability to glaucoma
by: Paul F. Cullen, et al.
Published: (2023-07-01)

The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
by: Mariafrancesca Scalise, et al.
Published: (2018-09-01)

A structural view onto disease-linked mutations in the human neutral amino acid exchanger ASCT1
by: Pavlo Stehantsev, et al.
Published: (2021-01-01)

Overexpression of low-density lipoprotein receptor prevents neurotoxic polarization of astrocytes via inhibiting NLRP3 inflammasome activation in experimental ischemic stroke
by: Shuai Feng, et al.
Published: (2025-02-01)

Editorial: The role of exosomes in neuroinflammation and neurodegeneration
by: Yi Wang, et al.
Published: (2022-12-01)

Epigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice
by: Jiesi Wang, et al.
Published: (2017-05-01)